TrueBlue TBI
TrueBlue FY 2020: net loss $141.8M; diluted EPS −$4.01
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0000768899-21-000085
- Document
- 10-K
- Exhibit 4.1
- Description of securities
- Exhibit 10.25
- Executive employment agreement
- Exhibit 10.26
- Third amendment to credit agreement
- Exhibit 10.27
- Restricted stock unit grant notice
- Exhibit 10.28
- Performance share unit grant notice
Key figures from this report
These are the numbers TrueBlue reported for the year ended Dec 27, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Net income−$141.8MNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$4.01No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$62.5MNo year-earlier figure tagged10-K balance sheet, on EDGAR
- Cash from operations$152.5MNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 7363 and related industry codes: the same peer list as the financial tables.
- Heidrick & Struggles International HSII
- Kelly Services KELYA public float $364M, Jun 29, 2025
- Cross Country Healthcare CCRN public float $393M, Jun 30, 2025
- RCM Technologies RCMT public float $99M, Jun 27, 2025
- Circle8 Group ATLN public float $98M, Jun 30, 2025